CoChat

Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information

Open access

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

Abstract

A new wave of portable biosensors allows frequent measurement of health-related physiology. We investigated the use of these devices to monitor human physiological changes during various activities and their role in managing health and diagnosing and analyzing disease. By recording over 250,000 daily measurements for up to 43 individuals, we found personalized circadian differences in physiological parameters, replicating previous physiological findings. Interestingly, we found striking changes in particular environments, such as airline flights (decreased peripheral capillary oxygen saturation [SpO2] and increased radiation exposure). These events are associated with physiological macro-phenotypes such as fatigue, providing a strong association between reduced pressure/oxygen and fatigue on high-altitude flights. Importantly, we combined biosensor information with frequent medical measurements and made two important observations: First, wearable devices were useful in identification of early signs of Lyme disease and inflammatory responses; we used this information to develop a personalized, activity-based normalization framework to identify abnormal physiological signals from longitudinal data for facile disease detection. Second, wearables distinguish physiological differences between insulin-sensitive and -resistant individuals. Overall, these results indicate that portable biosensors provide useful information for monitoring personal activities and physiology and are likely to play an important role in managing health and enabling affordable health care access to groups traditionally limited by socioeconomic class or remote geography.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pbio.2001402

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Overview of the project and summary of the devices. (A) Wearable devices used in this study. The different colors for the human figures indicate the specific studies in which each individual participated (i.e., red participated in all five studies, grey in two studies [Physiology/Activity and Insulin Sensitivity], blue in three studies [Physiology/Activity, Insulin Sensitivity, and Inflammation], orange and yellow in two studies [Physiology/Activity and Airflights], and green and pink in one study [Inflammation] and purple in one study [Airflights]). (B) The period during which the devices were used. The number of data points available for Participant #1 and others is indicated to the right. (C) The specific parameters measured by the different devices. The devices used to measure these parameters were represented by the color of the lines (MOVES: magenta; Basis: dark blue; Scanadu Scout: light green; iHealth-finger: brown; Masimo: orange; RadTarge: red; Withings: dark green). Dashed line indicates devices used frequently for discrete measurements; solid lines indicate devices that provide continuous measurement.
Fig 1 Overview of the project and summary of the devices. (A) Wearable devices used in this study. The different colors for the human figures indicate the specific studies in which each individual participated (i.e., red participated in all five studies, grey in two studies [Physiology/Activity and Insulin Sensitivity], blue in three studies [Physiology/Activity, Insulin Sensitivity, and Inflammation], orange and yellow in two studies [Physiology/Activity and Airflights], and green and pink in one study [Inflammation] and purple in one study [Airflights]). (B) The period during which the devices were used. The number of data points available for Participant #1 and others is indicated to the right. (C) The specific parameters measured by the different devices. The devices used to measure these parameters were represented by the color of the lines (MOVES: magenta; Basis: dark blue; Scanadu Scout: light green; iHealth-finger: brown; Masimo: orange; RadTarge: red; Withings: dark green). Dashed line indicates devices used frequently for discrete measurements; solid lines indicate devices that provide continuous measurement.CC0 · PubMed Central
Fig 2 Circadian and diurnal patterns in physiological parameters. Participant #1 hourly summaries in (A) sleep, (B) HRs, (C) skin temperature, and (D) steps as measured using the Basis Peak device over 71 nontravel d. (E) Summaries of 43-person cohort for daily HR and skin temperature from all data and (F) differences in resting (fewer than five steps) nighttime and daytime HRs (Note: one person did not have nighttime measurements and is not included) and skin temperature. (G) Daily activity plots for 43 individuals. Based on number of peaks in the curves, four general patterns of activity behavior are evident. The plots in Fig 2G were aligned according to the first increase in activity.
Fig 2 Circadian and diurnal patterns in physiological parameters. Participant #1 hourly summaries in (A) sleep, (B) HRs, (C) skin temperature, and (D) steps as measured using the Basis Peak device over 71 nontravel d. (E) Summaries of 43-person cohort for daily HR and skin temperature from all data and (F) differences in resting (fewer than five steps) nighttime and daytime HRs (Note: one person did not have nighttime measurements and is not included) and skin temperature. (G) Daily activity plots for 43 individuals. Based on number of peaks in the curves, four general patterns of activity behavior are evident. The plots in Fig 2G were aligned according to the first increase in activity.CC0 · PubMed Central
Fig 3 Physiological and activity profiles for 43 individuals. (A) The relationship between the average number of steps per day and resting HR (n = 43) and (B) average steps per minute and change in body mass index (BMI; n = 20) over the course of approximately 1 y was analyzed. Average resting HRs (C) were calculated by gender (see Material and Methods; n = 38).
Fig 3 Physiological and activity profiles for 43 individuals. (A) The relationship between the average number of steps per day and resting HR (n = 43) and (B) average steps per minute and change in body mass index (BMI; n = 20) over the course of approximately 1 y was analyzed. Average resting HRs (C) were calculated by gender (see Material and Methods; n = 38).CC0 · PubMed Central
Fig 4 SpO2 measurements during flight. (A) Example of a flight with continuous SpO2 measurements (blue) taken using a Masimo finger device. Altitude recorded using FlightAware (green). (B) Heat map showing distribution of SpO2 measurements recorded using a forehead Scanadu device at different flight stages: before takeoff, ascending, cruising, descending, and on ground post flight. (C) SpO2 levels recorded using iHealth-finger device during 2-h automobile ride over a mountain. Average measurements and standard error measured over a 15-min window (Blue). Altitude recorded from sign markers or town elevations and/or using DraftLogic website. (D) Distribution of SpO2 measurements taken from 18 individuals at cruising altitude (blue) versus on ground (green). (E) Distribution of SpO2 measurements after the participant reported feeling alert (red) or tired (cyan). (Upper panel) Measurements from nonflying days. (Lower panel) Measurements from flying days. The significance of the difference between the two distributions was assessed by two-sample Kolmogorov–Smirnov test. (F) Scatterplot of response time and SpO2 level recorded during one flight. The data recorded during another flight are shown in S5D Fig. The response time was derived from the psychomotor vigilance test to objectively quantify the fatigue of the participant. Self-reported tired and alert states are labeled by cyan triangles and red dots, respectively. (G) (Upper panel) Example of a flight with continuous SpO2 measurements (blue) taken using a Masimo finger device. Altitude recorded using FlightAware (green). Note the increase in SpO2 level towards the end of the flight. (Lower panel) Sleepiness recorded by Basis device. Magenta and cyan colors represent sleep and awake status, respectively. (H) A scatterplot of duration of time and the increase of SpO2 in the last quarter. All data points were collected at altitudes higher than 35,000 feet. (I) Empirical cumulative distribution function plot of SpO2 levels >7 h after takeoff (red) versus <2 h after takeoff (blue). All the data points were recorded at altitudes higher than 35,000 feet (p < 1e-307; two-sample Kolmogorov–Smirnov test).
Fig 4 SpO2 measurements during flight. (A) Example of a flight with continuous SpO2 measurements (blue) taken using a Masimo finger device. Altitude recorded using FlightAware (green). (B) Heat map showing distribution of SpO2 measurements recorded using a forehead Scanadu device at different flight stages: before takeoff, ascending, cruising, descending, and on ground post flight. (C) SpO2 levels recorded using iHealth-finger device during 2-h automobile ride over a mountain. Average measurements and standard error measured over a 15-min window (Blue). Altitude recorded from sign markers or town elevations and/or using DraftLogic website. (D) Distribution of SpO2 measurements taken from 18 individuals at cruising altitude (blue) versus on ground (green). (E) Distribution of SpO2 measurements after the participant reported feeling alert (red) or tired (cyan). (Upper panel) Measurements from nonflying days. (Lower panel) Measurements from flying days. The significance of the difference between the two distributions was assessed by two-sample Kolmogorov–Smirnov test. (F) Scatterplot of response time and SpO2 level recorded during one flight. The data recorded during another flight are shown in S5D Fig. The response time was derived from the psychomotor vigilance test to objectively quantify the fatigue of the participant. Self-reported tired and alert states are labeled by cyan triangles and red dots, respectively. (G) (Upper panel) Example of a flight with continuous SpO2 measurements (blue) taken using a Masimo finger device. Altitude recorded using FlightAware (green). Note the increase in SpO2 level towards the end of the flight. (Lower panel) Sleepiness recorded by Basis device. Magenta and cyan colors represent sleep and awake status, respectively. (H) A scatterplot of duration of time and the increase of SpO2 in the last quarter. All data points were collected at altitudes higher than 35,000 feet. (I) Empirical cumulative distribution function plot of SpO2 levels >7 h after takeoff (red) versus <2 h after takeoff (blue). All the data points were recorded at altitudes higher than 35,000 feet (p < 1e-307; two-sample Kolmogorov–Smirnov test).CC0 · PubMed Central
Fig 5 Elevated physiological measurements during infections. (A) Plot of fraction of outlying skin temperatures and HRs for all 679 d of Participant #1. Note all outlying time points correspond to periods when elevated high-sensitivity C-reactive protein (hs-CRP) measurements and/or illness were noted. The period harboring Lyme disease is expanded in panel B. (C) Decreased SpO2 measurements during the flight and subsequent period when aberrant physiological measurements were first noted; boxplot shows SpO2 distribution on Day 470 flight (blue) relative to similar length flights (green). The significance of this difference was assessed by two-sided Wilcoxon rank sum test. (D, E) CRP measurements are plotted against the proportion of daily HR measurements that were more than two SDs above the mean for Participant #58 (Pearson correlation coefficient = 0.90, p = 1.066e-05) (D) and Participant #59 (Pearson correlation coefficient = 0.966, p = 0.1653) (E). The timelines for the illness progression, CRP measurements, and Basis monitoring period captured in the figure are indicated for Participant #58 (two different illnesses separated by a period of ~11 mo) (Lower panel of D) and Participant #59 (Lower panel of E). (F) 679-d monitoring period of Participant #1. Left: normalized HR in minute resolution. Zoomed in at each illness period. Right: elevated CRP periods; G-H. Normalized HR at sick periods in minute resolution for Participant #58 (G) and Participant #59 (H). Red peak: Abnormal periods indicated by the peak caller. Red vertical line: CRP larger than 10; Green vertical line: CRP larger than three but smaller than ten. Yellow line: CRP smaller than three.
Fig 5 Elevated physiological measurements during infections. (A) Plot of fraction of outlying skin temperatures and HRs for all 679 d of Participant #1. Note all outlying time points correspond to periods when elevated high-sensitivity C-reactive protein (hs-CRP) measurements and/or illness were noted. The period harboring Lyme disease is expanded in panel B. (C) Decreased SpO2 measurements during the flight and subsequent period when aberrant physiological measurements were first noted; boxplot shows SpO2 distribution on Day 470 flight (blue) relative to similar length flights (green). The significance of this difference was assessed by two-sided Wilcoxon rank sum test. (D, E) CRP measurements are plotted against the proportion of daily HR measurements that were more than two SDs above the mean for Participant #58 (Pearson correlation coefficient = 0.90, p = 1.066e-05) (D) and Participant #59 (Pearson correlation coefficient = 0.966, p = 0.1653) (E). The timelines for the illness progression, CRP measurements, and Basis monitoring period captured in the figure are indicated for Participant #58 (two different illnesses separated by a period of ~11 mo) (Lower panel of D) and Participant #59 (Lower panel of E). (F) 679-d monitoring period of Participant #1. Left: normalized HR in minute resolution. Zoomed in at each illness period. Right: elevated CRP periods; G-H. Normalized HR at sick periods in minute resolution for Participant #58 (G) and Participant #59 (H). Red peak: Abnormal periods indicated by the peak caller. Red vertical line: CRP larger than 10; Green vertical line: CRP larger than three but smaller than ten. Yellow line: CRP smaller than three.CC0 · PubMed Central
Fig 6 HR differences in IR and sensitivity. Fit plots (A–D) of the linear regression models showing the associations between daytime (C), nighttime (D), delta (daytime minus nighttime) HR (A), and average daily steps (B) with SSPG levels. Higher SSPG levels indicate increased IR. An increase in delta HR and daytime HR is associated with a higher SSPG level, whereas an increase in average number of steps taken a day is associated with a lower SSPG level. There was no association with nighttime HR. Contour fit plot (E) and 3-D plot (F) of the multivariate regression demonstrating that delta HR and average daily steps each have an independent inverse association with SSPG. Parameter estimates were obtained using restricted maximum likelihood estimation with a robust variance estimator to account for unequal variances.
Fig 6 HR differences in IR and sensitivity. Fit plots (A–D) of the linear regression models showing the associations between daytime (C), nighttime (D), delta (daytime minus nighttime) HR (A), and average daily steps (B) with SSPG levels. Higher SSPG levels indicate increased IR. An increase in delta HR and daytime HR is associated with a higher SSPG level, whereas an increase in average number of steps taken a day is associated with a lower SSPG level. There was no association with nighttime HR. Contour fit plot (E) and 3-D plot (F) of the multivariate regression demonstrating that delta HR and average daily steps each have an independent inverse association with SSPG. Parameter estimates were obtained using restricted maximum likelihood estimation with a robust variance estimator to account for unequal variances.CC0 · PubMed Central
Fig 7 Exposure to radiation in daily life. Bar plot (upper panel: bars in blue) showing the amount of radiation that Participant #1 exposed to over a 25-d time window. Bar plot (lower panel: bars in magenta) showing the time that Participant #1 spent in airplane flights over the same time period. The maximum cruising altitude of each flight was labeled in the zoomed view of the bar plots. Asterisk represents the amount of radiation monitored during the airport carry-on luggage check (range 0.027 to 0.031 mRem). Other events that resulted in relatively high radiation are also labeled in the figure.
Fig 7 Exposure to radiation in daily life. Bar plot (upper panel: bars in blue) showing the amount of radiation that Participant #1 exposed to over a 25-d time window. Bar plot (lower panel: bars in magenta) showing the time that Participant #1 spent in airplane flights over the same time period. The maximum cruising altitude of each flight was labeled in the zoomed view of the bar plots. Asterisk represents the amount of radiation monitored during the airport carry-on luggage check (range 0.027 to 0.031 mRem). Other events that resulted in relatively high radiation are also labeled in the figure.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

Metadata

Authors
Li, X., Dunn, J., Salins, D., Zhou, G., Zhou, W., Schüssler-Fiorenza Rose, S. M., Perelman, D., Colbert, E., Runge, R., Rego, S., Sonecha, R., Datta, S., McLaughlin, T., & Snyder, M. P.
Affiliations
  • Stanford Medicine (US)
  • VA Palo Alto Health Care System (US)
Corresponding author
Snyder, Michael P.
Venue
PLOS Biology
Published
2017-01-12
Volume
15
Issue
1
Pages
e2001402
ISSN
  • 1544-9173 (ISSN-L)
  • 1545-7885
OpenAlex
W2575460524
Cited by
431
References
63
Citations by year
2026: 34 · 2025: 37 · 2024: 37 · 2023: 47 · 2022: 58 · 2021: 61 · 2020: 52 · 2019: 37 · 2018: 42 · 2017: 26
FWCI
19.31
Type
journal article
Language
en
Open access
Locations
  • PLoS Biology (publishedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • U.S. Department of Veterans Affairs
  • Intel Corporation
  • National Institutes of Health (UL1TR001085)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U54DK102556)
  • National Institute of Biomedical Imaging and Bioengineering (U54EB020405)
  • National Center for Advancing Translational Sciences
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Context-Aware Activity Recognition Systems
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
Keywords
wearable biosensors, physiological monitoring, circadian rhythm, fatigue, high-altitude flight, hypoxia, capillary oxygen saturation, radiation exposure, inflammation, insulin resistance, disease detection, remote care
MeSH terms
Circadian Rhythm, Electronics, Medical, Health, Humans, Inflammation, Insulin, Insulin Resistance, Oxygen, Partial Pressure, Radiation, Reproducibility of Results, Biosensing Techniques, Precision Medicine, Patient-Specific Modeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.